Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma

Journal of the Formosan Medical Association

Volumn 112, Issue 7, 2013, Pages 382-389

  Chung, Kun Ming ^a   Chang, Sheng Tsung ^a,h   Huang, Wen Tsung ^a   Lu, Chin Li ^a   Wu, Hung Chang ^a   Hwang, Wei Shou ^b,c   Chang, Kwang Yu ^d,e,f   Chuang, Shih Sung ^a,g  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h NATIONAL TAINAN INSTITUTE OF NURSING   (Taiwan)

Author keywords

Bcl 6; Diffuse large B cell lymphoma; Germinal center B cell phenotype; Primary gastric lymphoma; Stomach; Taiwan

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERFERON REGULATORY FACTOR 4; LACTATE DEHYDROGENASE; PREDNISOLONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE;

ADULT; ALGORITHM; ARTICLE; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GERMINAL CENTER; HUMAN; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MALE; MORBIDITY; OVERALL SURVIVAL; PHENOTYPE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH DIFFUSE LARGE CELL LYMPHOMA; STOMACH LYMPHOMA; STOMACH OBSTRUCTION; SURVIVAL RATE;

BCL-6; DIFFUSE LARGE B-CELL LYMPHOMA; GERMINAL CENTER B-CELL PHENOTYPE; PRIMARY GASTRIC LYMPHOMA; STOMACH; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; FEMALE; HUMANS; HYDRO-LYASES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84881552886     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.07.031     Document Type: Article

References (41)

1. Isaacson P.G., Du M.Q. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 2005, 205:255-274.
2. Freeman C., Berg J.W., Cutler S.J. Occurrence and prognosis of extranodal lymphomas. Cancer 1972, 29:252-260.
3. Weingrad D.N., Decosse J.J., Sherlock P., Straus D., Lieberman P.H., Filippa D.A. Primary gastrointestinal lymphoma: a 30-year review. Cancer 1982, 49:1258-1265.
4. Dragosics B., Bauer P., Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer 1985, 55:1060-1073.
5. Zinzani P.L., Magagnoli M., Pagliani G., Bendandi M., Gherlinzoni F., Merla E., et al. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica 1997, 82:305-308.
6. Stein H., Warnke R.A., Chan W.C., Jaffe E.S. Diffuse large B-cell lymphoma, not otherwise specified. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 233-237. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein (Eds.).
7. Offit K., Lo Coco F., Louie D.C., Parsa N.Z., Leung D., Portlock C., et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994, 331:74-80.
8. de Leval L., Harris N.L. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance. Histopathology 2003, 43:509-528.
9. Chuang S.S., Lee C., Hamoudi R.A., Liu H., Lee P.S., Ye H., et al. High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation. Br J Haematol 2003, 120:97-100.
10. Kuo S.H., Chen L.T., Yeh K.H., Wu M.S., Hsu H.C., Yeh P.Y., et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004, 22:3491-3497.
11. Liu T.Y., Dei P.H., Kuo S.H., Lin C.W. Early low-grade gastric MALToma rarely transforms into diffuse large cell lymphoma or progresses beyond the stomach and regional lymph nodes. J Formos Med Assoc 2010, 109:463-471.
12. Chuang S.S., Ye H., Yang S.F., Huang W.T., Chen H.K., Hsieh P.P., et al. Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma. Histopathology 2008, 53:432-440.
13. Edge S.B., Byrd D.R., Compton C.C., Firtz A.G., Greene V.L., Trotti A. Lymphoid neoplasms. AJCC cancer staging manual 2010, Springer, New York, 599-628.
14. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275-282.
15. Muris J.J., Meijer C.J., Vos W., van Krieken J.H., Jiwa N.M., Ossenkoppele G.J., et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 2006, 208:714-723.
16. Rohatiner A., d'Amore F., Coiffier B., Crowther D., Gospodarowicz M., Isaacson P., et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994, 5:397-400.
17. Colucci G., Naglieri E., Maiello E., Marzullo F., Caruso M.L., Leo S., et al. Role of prognostic factors in the therapeutic strategy of primary gastric non Hodgkin's lymphomas. Clin Ter 1998, 149:25-30.
18. Hsi E.D., Eisbruch A., Greenson J.K., Singleton T.P., Ross C.W., Schnitzer B. Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol 1998, 22:17-27.
19. Mäkelä J., Karttunen T., Kiviniemi H., Laitinen S. Clinicopathological features of primary gastric lymphoma. J Surg Oncol 1999, 70:78-82.
20. Cogliatti S.B., Schmid U., Schumacher U., Eckert F., Hansmann M.L., Hedderich J., et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991, 101:1159-1170.
21. Chen Y.W., Hu X.T., Liang A.C., Au W.Y., So C.C., Wong M.L., et al. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma. Blood 2006, 108:2373-2383.
22. Takeshita M., Iwashita A., Kurihara K., Ikejiri K., Higashi H., Udoh T., et al. Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma. Am J Surg Pathol 2000, 24:1641-1649.
23. Barrans S.L., Evans P.A., O'Connor S.J., Kendall S.J., Owen R.G., Haynes A.P., et al. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin Cancer Res 2003, 9:2133-2139.
24. Basso K., Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol 2010, 105:193-210.
25. Lin C.H., Kuo K.T., Chuang S.S., Kuo S.H., Chang J.H., Chang K.C., et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin Cancer Res 2006, 12:1152-1156.
26. Ninan M.J., Wadhwa P.D., Gupta P. Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2011, 52:360-373.
27. Winter J.N., Weller E.A., Horning S.J., Krajewska M., Variakojis D., Habermann T.M., et al. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood 2006, 107:4207-4213.
28. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
29. Rosenwald A., Wright G., Chan W.C., Connors J.M., Campo E., Fisher R.I., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947.
30. Berglund M., Thunberg U., Amini R.M., Book M., Roos G., Erlanson M., et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol 2005, 18:1113-1120.
31. Sjö L.D., Poulsen C.B., Hansen M., Møller M.B., Ralfkiaer E. Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. Eur J Haematol 2007, 79:501-507.
32. Yamauchi A., Fujita S., Ikeda J., Nakamichi I., Fukuhara S., Hino M., et al. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group. Am J Hematol 2007, 82:893-897.
33. Meyer P.N., Fu K., Greiner T.C., Smith L.M., Delabie J., Gascoyne R.D., et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 2011, 29:200-207.
34. Gutiérrez-García G., Cardesa-Salzmann T., Climent F., González-Barca E., Mercadal S., Mate J.L., et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood 2011, 117:4836-4843.
35. Thieblemont C., Briere J., Mounier N., Voelker H.U., Cuccuini W., Hirchaud E., et al. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. J Clin Oncol 2011, 29:4079-4087.
36. Chuang S.S., Ye H., Du M.Q., Lu C.L., Dogan A., Hsieh P.P., et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol 2007, 128:558-564.
37. Connor J., Ashton-Key M. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study. Histopathology 2007, 51:697-703.
38. Mitchell K.A., Finn W.G., Owens S.R. Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas. Leuk Lymphoma 2008, 49:1717-1723.
39. Chuang S.S., Chang S.T., Chuang W.Y., Huang W.T., Hsieh P.P., Tsou M.H., et al. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas. Am J Surg Pathol 2009, 33:1230-1240.
40. Al-Akwaa A.M., Siddiqui N., Al-Mofleh I.A. Primary gastric lymphoma. World J Gastroenterol 2004, 10:5-11.
41. Maisey N., Norman A., Prior Y., Cunningham D. Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications?. Clin Oncol (R Coll Radiol) 2004, 16:48-52.